December 06, 2016
from PreventDisease Website
Moreover, the overall contribution of cytotoxic chemotherapy to 5-year survival in adults is below 3 percent.
Between 2005 and 2015, cancer cases increased by
33 percent and the number of new cases is expected to
rise by about 70% over the next just two decades under the current
global disease promoting paradigm.
The report (Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost) by Christina Fitzmaurice, M.D., M.P.H., of the University of Washington, Seattle and coauthors estimated cancer deaths using vital registration system data, cancer registry incidence data and verbal autopsy data.
Other key findings from the report were:
Part of the failure in treating cancer is our reliance on cytotoxic drugs, especially conventional chemotherapy used broadly across the world.
As more people abstain from using chemotherapy as a treatment for cancer, more people are surviving.
Oncologists recommend cytotoxic chemotherapy for most patients for the palliation of symptoms and to and improve quality of life. It is aims at improving survival.
None of the above has materialized as truth for the cancer industry since the inception of the treatment and despite the use of new and expensive single and combination drugs to improve response rates and other agents to allow for dose escalation, there has been no change for the regimens used.
Most statistics simply highlight that
patients are "still alive" at the five year mark. Most still had
cancer and many died of cancer later.
A "magic bullet" would cost
the drug companies hundreds of
billions of dollars, and patients would have less hospitalization
and less doctor visits, etc...
They are all poisons...
Consume or inject enough poison into your body and you will eventually die. Toxic chemotherapy drugs just happen to take a little longer than many of those above, and they're designed that way.
According to official statistics, one person out of two is claimed to recover from cancer through conventional methods. Although dramatic, the information nevertheless contains a certain amount of hope, as implicitly it provides something positive for both scientists and patients.
To the scientists it says:
To the patients, on the other hand, it provides a warning:
There is an international classification (the TNM system) that classifies tumors on the basis of their gravity.
They are subdivided into stages I, II,
III, IV, and into sub-groups. It is clear to any trained eye that
initial lesions that are doubtful or at the limit of malignancy
represent the overwhelming majority of the observed "neoplasias".
The reason for the discrepancy is the qualification of the data and how a patient is assessed in terms of recovery.
...are NEVER inclusively assessed in any clinical study discussing the long-term survival and recovery rates of cancer patients.
The damage to these systems slowly develops after chemotherapy, however if often does not begin to manifest throughout the body until several months or even years have passed.
It takes time, but within a 3-5 year
period, most chemotherapy patients begin to have many more symptoms
of disease than they every had before their diagnosis, due to and as
a direct result of cytotoxic drug intervention.
A study in the Annals of Oncology (Long-term Toxic Effects of Adjuvant Chemotherapy in Breast Cancer) is one of few which assessed the different potential long-term adverse events associated with adjuvant chemotherapy in cancer, with a particular focus on long-term cardiac toxicity, secondary leukemia, cognitive function, and neurotoxicity.
The authors stated that the adverse
events are frequently overshadowed by the well-demonstrated clinical
efficacy and/or reassuring short-term safety profiles of the
different chemotherapy regimens commonly used today.
They observed a significantly increased risk for occurrence of cardiac events accompanied by a persisting unfavorable cardiovascular risk profile likely due to chemotherapeutic agents.
Peter Glidden, BS, ND in the video above describes the 12-year meta-analysis published in the Journal of Clinical Oncology which observed adults who had developed cancer and treated with chemotherapy.
The 12-year study looked at adults who had developed cancer as an adult. 97% of the time, chemotherapy did not work in regressing the metastatic cancers.
Chemotherapy Actually Boosts Cancer Growth
Chemotherapy works by inhibiting reproduction of fast-dividing cells such as those found in tumors.
The scientists found that healthy cells damaged by chemotherapy secreted more of a protein called WNT16B which boosts cancer cell survival.
The protein was taken up by tumor cells neighboring the damaged cells.
In cancer treatment, tumors often respond well initially, followed by rapid re-growth and then resistance to further chemotherapy.
Rates of tumor cell reproduction have been shown to accelerate between treatments.
The researchers said they confirmed their findings with breast and ovarian cancer tumors.
Patients with incurable cancers are promised much greater access to the latest drugs which could offer them extra months or years of life.
However many doctors have been urged to be more cautious in offering cancer treatment to terminally-ill patients as chemotherapy can often do more harm than good, advice supported by Nelson's study.
Doctors Speak Out About The Cancer Industry
They're natural, effective, and inexpensive, no expensive drugs are involved but they require quite a lot of self-discipline from patients. It costs millions to fund research and clinical trials needed to produce a new cancer drug that can be patented and sold.
Often these drugs create more illness. It has been said that the key to success in the health business is to pull off the trick of making people patients for life.
Consider how many people who registered
a couple of abnormal blood pressure readings have been kept on
medication until the medication killed them, when a quick fix course
of drugs supported by major changes of diet and lifestyle would have
returned their physical condition to an unmedicated healthy state.
Dr. Glenn Warner, who died in 2000, was one of the most highly qualified cancer specialists in the United States. He used alternative treatments on his cancer patients with great success.
On the treatment of cancer in this country he said:
Dr. Alan C. Nixon, past president of the American Chemical Society writes,
And according to Dr. Charles Mathe, French cancer specialist,
Dr. Allen Levin stated:
In his book, The Topic of Cancer - When the Killing Has to Stop, Dick Richards cites a number of autopsy studies which have shown that cancer patients actually died from conventional treatments before the tumor had a chance to kill them...